GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$14.16
+2.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 116.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.99x
- Price / sales
- 56.99x
- Price / cash flow
- -9.06x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 44.61x
- EV / EBITDA
- -6.82x
- EV / EBIT
- -6.05x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026